These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9125873)

  • 1. [Usefulness of MR imaging in evaluating and predicting effect of neoadjuvant chemotherapy on uterine cervical carcinoma].
    Amano M; Kato T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1997 Mar; 57(4):176-81. PubMed ID: 9125873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E; Mathews RP; Gates J; Levine P; Maiman M; Remy JC
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor response to neoadjuvant chemotherapy correlates with the expression of P-glycoprotein and PCNA but not GST-pi in the tumor cells of cervical carcinoma.
    Konishi I; Nanbu K; Mandai M; Tsuruta Y; Kataoka N; Nagata Y; Mori T
    Gynecol Oncol; 1998 Sep; 70(3):365-71. PubMed ID: 9790789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neoadjuvant chemotherapy with intra-arterial infusion in the treatment of advanced cervical cancer].
    Mizuno K; Kidokoro K; Miyazaki K; Yoshida K; Nakagawa A; Mizuno M; Suzuki S; Kuno N; Furuhashi M; Ishizuka T; Ishikawa K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):815-9. PubMed ID: 15984522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of advanced or recurrent cervical carcinoma with a consecutive low-dose cisplatin combined with bleomycin, vincristine, and mitomycin-C (consecutive low-dose BOMP).
    Shimizu Y
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():359-77. PubMed ID: 10895181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of neoadjuvant chemotherapy with mitomycin-c, vincristine and cisplatin (MVC) in patients with stages IB2-IIB cervical carcinoma.
    Choi CH; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
    Gynecol Oncol; 2007 Jan; 104(1):64-9. PubMed ID: 16904170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoadjuvant chemotherapy for advanced cervical cancer].
    Kodama J; Ikuhashi H; Hongo A; Mizutani Y; Miyagi Y; Yoshinouchi M; Kobashi Y; Okuda H; Kudo T
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):89-92. PubMed ID: 9987503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant intraarterial infusion chemotherapy in patients with stage IB2-IIIB cervical cancer.
    Yamakawa Y; Fujimura M; Hidaka T; Hori S; Saito S
    Gynecol Oncol; 2000 May; 77(2):264-70. PubMed ID: 10785476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of p53 and apoptosis of tumor cells in locally advanced cervical carcinoma after cisplatin based neoadjuvant chemotherapy.
    Garzetti GG; Ciavattini A; Provinciali M; Di Stefano G; Lucarini G; Goteri G; Biagini G
    Anticancer Res; 1996; 16(5B):3229-34. PubMed ID: 8920796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of VEGF expression in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy.
    Choi CH; Song SY; Choi JJ; Park YA; Kang H; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
    BMC Cancer; 2008 Oct; 8():295. PubMed ID: 18847499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using MR imaging to predict and evaluate the response of invasive cervical carcinoma to systemic chemotherapy.
    Amano M; Kato T; Amano Y; Kumazaki T
    AJR Am J Roentgenol; 1998 Nov; 171(5):1335-9. PubMed ID: 9798875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
    Lai CH; Hsueh S; Chang TC; Tseng CJ; Huang KG; Chou HH; Chen SM; Chang MF; Shum HC
    Gynecol Oncol; 1997 Mar; 64(3):456-62. PubMed ID: 9062150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraarterial chemotherapy for uterine cervical adenocarcinoma: evaluation of its efficacy as neoadjuvant therapy].
    Usuki N; Hirokawa K; Tashiro T; Saiwai S; Miyamoto T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Oct; 59(12):670-3. PubMed ID: 10565169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in tumor volume and histologic response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma.
    Fujiwaki R; Takahashi K; Kitao M
    Gynecol Oncol; 1997 May; 65(2):258-64. PubMed ID: 9159335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of neoadjuvant chemotherapy in the treatment of patients with stage IIIB cervical cancer].
    Gorchev G; Kornovski Ia
    Akush Ginekol (Sofiia); 2003; 42(6):21-4. PubMed ID: 15067810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of tumor size on MR imaging in assessing the prognosis of uterine cervical cancer treated with radiation].
    Hayashi T; Kato T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 May; 59(6):250-5. PubMed ID: 10388310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment serum hemoglobin level as a predictive factor of response to neoadjuvant chemotherapy in patients with locally advanced squamous cervical carcinoma: a preliminary report.
    Fuso L; Mazzola S; Marocco F; Ferrero A; Dompè D; Carus AP; Zola P
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S187-91. PubMed ID: 16185756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.